Uri Abadi
Impact in
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
- Hematology top 10%
- Platelet Disorders and Treatments
Papers in
- Oncology 13
- CAR-T cell therapy research 10
-
- Lymphoma Diagnosis and Treatment 11
- Co-authors
- Gideon Koren (1 shared paper)Michael Lishner (1 shared paper)Martin Ellis (9 shared papers)Gila Sellam (4 shared papers)Itai Levi (4 shared papers)Sunil Babu (4 shared papers)Houston Holmes (3 shared papers)Abraham Avigdor (5 shared papers)
- Journals
- Blood (10 papers)Hematological Oncology (4 papers)Annals of Hematology (2 papers)Hematology/Oncology Clinics of North America (1 paper)British Journal of Haematology (1 paper)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Uri Abadi
26 papers receiving 296 citations
Peers
Comparison fields: 5 of 52
- Pathology and Forensic Medicine 129
- Hematology 71
- Oncology 141
- Genetics 35
- Hepatology 19
Countries citing papers authored by Uri Abadi
This map shows the geographic impact of Uri Abadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uri Abadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uri Abadi more than expected).
Fields of papers citing papers by Uri Abadi
This network shows the impact of papers produced by Uri Abadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uri Abadi. The network helps show where Uri Abadi may publish in the future.
Co-authors
The 25 scholars most cited alongside Uri Abadi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 44 | |
| 2 | 2020 | 43 | |
| 3 | 2000 | 37 | |
| 4 | 2022 | 27 | |
| 5 | 2017 | 26 | |
| 6 | 2014 | 24 | |
| 7 | 2019 | 16 | |
| 8 | 2019 | 12 | |
| 9 | 2024 | 9 | |
| 10 | 2017 | 8 | |
| 11 | 2019 | 6 | |
| 12 | 2023 | 5 | |
| 13 | Myositis in Behcet's disease after tonsillectomy. | 2006 | 5 |
| 14 | 2011 | 4 | |
| 15 | 2021 | 4 | |
| 16 | 2019 | 4 | |
| 17 | 2021 | 4 | |
| 18 | 2021 | 4 | |
| 19 | 2014 | 3 | |
| 20 | 2021 | 3 |
About Uri Abadi
Uri Abadi is a scholar working on Oncology, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging, Hematology and Genetics, having authored 28 papers that have together received 298 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (11 papers), CAR-T cell therapy research (10 papers), Chronic Lymphocytic Leukemia Research (4 papers), Cell Adhesion Molecules Research (3 papers), CNS Lymphoma Diagnosis and Treatment (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Autoimmune and Inflammatory Disorders Research (2 papers) and Cutaneous lymphoproliferative disorders research (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (129 citations), Hematology (71 citations), Oncology (141 citations), Genetics (35 citations) and Hepatology (19 citations). Uri Abadi has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Gideon Koren, Michael Lishner, Martin Ellis, Gila Sellam, Itai Levi, Sunil Babu, Houston Holmes, Abraham Avigdor, Netanel A. Horowitz and Naseer Qayum. Their work appears in journals such as Blood, Hematological Oncology, Annals of Hematology, Hematology/Oncology Clinics of North America and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.